Astrazeneca (AZN) Goodwill (2009 - 2026)

Astrazeneca (AZN) has reported Goodwill for 18 consecutive years, with $21.2 billion the latest figure, recorded in Q1 2026.

• In Q1 2026, Goodwill changed 0.3% year-over-year to $21.2 billion; the TTM figure through Mar 2026 stood at $21.2 billion (changed 0.3% YoY), while the FY2025 annual figure was $21.2 billion, up 1.03% from the prior year.
• Goodwill came in at $21.2 billion for Q1 2026 at Astrazeneca, roughly flat from $21.2 billion in the prior quarter.
• The five-year high for Goodwill was $21.2 billion in Q4 2025, with the low at -$313.0 million in Q4 2023.
• Average Goodwill over 5 years is $19.3 billion, with a median of $20.0 billion recorded in 2023.
• Across the five-year window, Goodwill slumped 101.58% in 2023 and jumped 6817.25% in 2024, its largest moves.
• Year by year, Goodwill stood at $19.8 billion in 2022, then sank by 101.58% to -$313.0 million in 2023, then surged by 6817.25% to $21.0 billion in 2024, then grew by 1.03% to $21.2 billion in 2025, then slipped by 0.23% to $21.2 billion in 2026.
• According to Business Quant data, Goodwill over the past three periods registered $21.2 billion, $21.2 billion, and $21.2 billion for Q1 2026, Q4 2025, and Q3 2025 respectively.